These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1679 related items for PubMed ID: 24685689

  • 1. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D, Sato A, Hoshi T, Maruta S, Misaki M, Kakefuda Y, Watabe H, Hiraya D, Sakai S, Kawabe M, Takeyasu N, Aonuma K.
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [Abstract] [Full Text] [Related]

  • 2. Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study.
    Wijnbergen I, Helmes H, Tijssen J, Brueren G, Peels K, van Dantzig JM, Van' t Veer M, Koolen JJ, Pijls NH, Michels R.
    JACC Cardiovasc Interv; 2012 Mar; 5(3):313-22. PubMed ID: 22440498
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH, Fang Q, Zhang SY, Shen ZJ, Fan ZJ, Jin XF, Zeng Y, Liu ZY, Xie HZ, Yang M.
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [Abstract] [Full Text] [Related]

  • 5. Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents following successful PCI in non-ST-elevation myocardial infarction: findings from the Guthrie Health Off-Label StenT (GHOST) Registry.
    Harjai KJ, Sattur S, Orshaw P, Boura J.
    J Interv Cardiol; 2012 Feb; 25(1):28-36. PubMed ID: 21981467
    [Abstract] [Full Text] [Related]

  • 6. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
    Sabaté M, Räber L, Heg D, Brugaletta S, Kelbaek H, Cequier A, Ostojic M, Iñiguez A, Tüller D, Serra A, Baumbach A, von Birgelen C, Hernandez-Antolin R, Roffi M, Mainar V, Valgimigli M, Serruys PW, Jüni P, Windecker S.
    JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
    [Abstract] [Full Text] [Related]

  • 7. Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group.
    Brodie BR, Stuckey T, Downey W, Humphrey A, Nussbaum M, Laurent S, Bradshaw B, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Simonton CA, Strategic Transcatheter Evaluation of New Therapies (STENT) Group.
    Catheter Cardiovasc Interv; 2008 Dec 01; 72(7):893-900. PubMed ID: 19016465
    [Abstract] [Full Text] [Related]

  • 8. Comparison between drug-eluting and bare metal stent on ST-elevation myocardial infarction outcome: should second-generation drug-eluting stent be preferred?
    Giglioli C, Cecchi E, Vladi L, Stolcova M, Valente S, Meucci F, Baldereschi GJ, Chiostri M, Romano SM, Gensini GF, Barchielli A, Balzi D.
    J Cardiol; 2014 Apr 01; 63(4):296-301. PubMed ID: 24365386
    [Abstract] [Full Text] [Related]

  • 9. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Daemen J, Gaspersz M, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P.
    J Invasive Cardiol; 2011 Aug 01; 23(8):336-41. PubMed ID: 21828397
    [Abstract] [Full Text] [Related]

  • 10. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
    Sabaté M, Brugaletta S, Cequier A, Iñiguez A, Serra A, Hernádez-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Backx B, Serruys PW.
    JACC Cardiovasc Interv; 2014 Jan 01; 7(1):64-71. PubMed ID: 24332423
    [Abstract] [Full Text] [Related]

  • 11. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA, Dirksen MT, Suttorp MJ, Tijssen JG, van Etten J, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ.
    JACC Cardiovasc Interv; 2011 Jan 01; 4(1):24-9. PubMed ID: 21251625
    [Abstract] [Full Text] [Related]

  • 12. Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.
    Bangalore S, Amoroso N, Fusaro M, Kumar S, Feit F.
    Circ Cardiovasc Interv; 2013 Aug 01; 6(4):378-90. PubMed ID: 23922145
    [Abstract] [Full Text] [Related]

  • 13. Safety and effectiveness of drug eluting stent in patients with ST elevation myocardial infarction undergoing primary angioplasty.
    Romano M, Buffoli F, Tomasi L, Corrado L, Ferrari MR, Zanini R.
    Catheter Cardiovasc Interv; 2008 May 01; 71(6):759-63. PubMed ID: 18412066
    [Abstract] [Full Text] [Related]

  • 14. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.
    JACC Cardiovasc Interv; 2013 Dec 01; 6(12):1242-9. PubMed ID: 24355114
    [Abstract] [Full Text] [Related]

  • 15. Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.
    Harjai KJ, Kondareddy S, Pinkosky B, Harjai N, Orshaw P, Boura J.
    J Interv Cardiol; 2013 Apr 01; 26(2):153-62. PubMed ID: 23363439
    [Abstract] [Full Text] [Related]

  • 16. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E, Mangiacapra F, Peace A, Ntarladimas Y, Conte M, Bartunek J, Vanderheyden M, Wijns W, de Bruyne B, Barbato E.
    Arch Cardiovasc Dis; 2013 Nov 01; 106(11):554-61. PubMed ID: 24231052
    [Abstract] [Full Text] [Related]

  • 17. In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: a report from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
    Gordon PC, Cohen DJ, Kleiman NS, Montgomery JA, Semder CA, Kennedy KF, Keyes MJ, Piana RN, EVENT Investigators.
    Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):E356-64. PubMed ID: 22511502
    [Abstract] [Full Text] [Related]

  • 18. Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry.
    Jeger R, Jaguszewski M, Nallamothu BN, Lüscher TF, Urban P, Pedrazzini GB, Erne P, Radovanovic D, AMIS Plus Investigators.
    Int J Cardiol; 2014 Mar 01; 172(1):76-81. PubMed ID: 24461983
    [Abstract] [Full Text] [Related]

  • 19. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients.
    Contini GA, Nicolini F, Fortuna D, Pacini D, Gabbieri D, Vignali L, Valgimigli M, Manari A, Zussa C, Guastaroba P, De Palma R, Grilli R, Gherli T.
    Int J Cardiol; 2013 Sep 30; 168(2):1028-33. PubMed ID: 23164591
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
    Campo G, Saia F, Percoco G, Manari A, Santarelli A, Vignali L, Varani E, Benassi A, Sangiorgio P, Tarantino F, Magnavacchi P, De Palma R, Guastaroba P, Marzocchi A.
    Int J Cardiol; 2010 Apr 15; 140(2):154-60. PubMed ID: 19056134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 84.